Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
55
Millions of yenWording
Conditional
How definitive the wording is.Results for this period
First quarter2025年７月１日～2025年９月30日ConsolidatedJapanese GAAPNet Sales1,317Millions of yenYear on year +22.1%Progress 26.6%
Operating profit55Millions of yenProgress 48.2%
Ordinary income58Millions of yenProgress 65.2%
Net income attributable to owners of the parent54Millions of yenProgress 70.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥2.00
Financial position at period-end
Total assets5,157Millions of yen
of which net assets 3,811 Millions of yenEquity ratio 73.9%vs. prior year-end -2.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenuenot disclosed (omitted because the company has a single segment)
Segment profitnot disclosed (omitted because the company has a single segment)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales4,942 Millions of yen (YoY +5.3%)
Operating profit114 Millions of yen
Ordinary income89 Millions of yen
Net income77 Millions of yen
Annual Dividend Forecast¥0 → Undecided
Factors Behind Changes in Business Performance
PSSプラットフォーム装置の販売が堅調に推移し、累計出荷台数の増加に伴い核酸抽出試薬及び関連消耗品の売上が伸長した。抜本的な事業再編と各費用抑制施策により販売費及び一般管理費が減少した。
Disclosure regarding the going concern assumption
重要事象等の記載あり。事業再生フェーズにあり、継続企業の前提に重要な疑義を生じさせる事象及び状況は存在するものの、重要な不確実性は認められないと判断している。なお、継続企業の前提に関する注記は該当事項なし。
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 companies / Excluded 1社（エヌピーエス株式会社）
Material subsequent events2025年10月24日に、業績条件型譲渡制限付株式報酬として自己株式270,000株を取締役5名に処分。処分総額は56,160,000円。
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on sale of fixed assets ¥0 thousand, Loss on Disposal of Fixed Assets ¥0 thousand, Business-structure improvement costs ¥85 thousand, Loss on changes in equity interests ¥2,237 thousand
Depreciation and amortization¥53,005 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End27,666,900 shares
Treasury Shares at Period-End476,129株
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年７月１日～2025年９月30日 |
| Net Sales | 1,317 Millions of yen (YoY +22.1%) |
| Operating profit | 55 Millions of yen |
| Ordinary income | 58 Millions of yen |
| Profit attributable to owners of the parent | 54 Millions of yen |
| Net income per share | ¥2.00 |
| Equity ratio | End of the current fiscal period 73.9 / End of previous period 76.2 |
| Total assets | 5,157 Millions of yen |
| Net assets | 3,811 Millions of yen |
| Full-year earnings forecast | Net Sales 4,942 Millions of yen (YoY +5.3%) / Operating profit 114 Millions of yen / Ordinary income 89 Millions of yen / Net income 77 Millions of yen |
| Annual Dividend Forecast | ¥0 → Undecided |
| Segment revenue | not disclosed (omitted because the company has a single segment) |
| Segment profit | not disclosed (omitted because the company has a single segment) |
| Depreciation and amortization | ¥53,005 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on sale of fixed assets ¥0 thousand, Loss on Disposal of Fixed Assets ¥0 thousand, Business-structure improvement costs ¥85 thousand, Loss on changes in equity interests ¥2,237 thousand |
| Disclosure regarding the going concern assumption | 重要事象等の記載あり。事業再生フェーズにあり、継続企業の前提に重要な疑義を生じさせる事象及び状況は存在するものの、重要な不確実性は認められないと判断している。なお、継続企業の前提に関する注記は該当事項なし。 |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 1社（エヌピーエス株式会社） |
| Material subsequent events | 2025年10月24日に、業績条件型譲渡制限付株式報酬として自己株式270,000株を取締役5名に処分。処分総額は56,160,000円。 |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 27,666,900 shares |
| Treasury Shares at Period-End | 476,129株 |
| Factors Behind Changes in Business Performance | PSSプラットフォーム装置の販売が堅調に推移し、累計出荷台数の増加に伴い核酸抽出試薬及び関連消耗品の売上が伸長した。抜本的な事業再編と各費用抑制施策により販売費及び一般管理費が減少した。 |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.PSSプラットフォーム装置の販売が堅調に推移し、累計出荷台数の増加に伴って核酸抽出試薬・関連消耗品の売上が伸長しました。また、抜本的な事業再編と各費用抑制施策により販売費及び一般管理費が減少しました。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.